The size of protein-based drug molecules prevents their absorption into the body when taken orally making injection (intramuscularly, subcutaneously, intravenously, etc.) the only effective delivery ...

The FDA has approved MediBeacon®'s TGFR system for noninvasive kidney function assessment, targeting both normal and impaired renal patients. INNOVATE Corp. announced the FDA approval of the ...

The TRX-248 Transdermal System led to steady and continuous levels of treprostinil in the plasma over 24 hours and a low peak-to-trough fluctuation.

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have Chronic ...

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue Purdue announced that Butrans (buprenorphine) Transdermal System will be available for ordering the week of January 10, ...

Transdermal drug delivery is valued by patients and physicians for the comfort and convenience it offers — no needles, no pills and ease of use Transdermal drug delivery is valued by patients and ...

Purpose: The efficacy and safety of fentanyl hydrochloride patient-controlled trans-dermal system (PCTS) for management of acute postoperative pain are discussed. Summary: Fentanyl hydrochloride PCTS ...

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.

The approval granted by the US Food and Drug Administration (USFDA) is to market the Scopolamine transdermal system of dosage 1 mg/3 days, Zydus Lifesciences said in a regulatory filing. New Delhi: ...

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe ...

The first ondansetron orally dissolving film (ODF) has been approved in Japan, validating TAHO’s platform technology from prototype to commercial product. Transdermal patches and ODFs can enhance the ...

The company is recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because of possible multi-stacking of patches. Alvogen announced on Jan. 31, 2025 that it is voluntarily ...